Farglitazar

CAS No. 196808-45-4

Farglitazar( —— )

Catalog No. M34248 CAS No. 196808-45-4

Farglitazar (GI-262570) is a PPAR-γ agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor γ via oxidative enzymes proliferators and is used in the study of diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 710 In Stock
5MG 588 In Stock
10MG 777 In Stock
25MG 1197 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Farglitazar
  • Note
    Research use only, not for human use.
  • Brief Description
    Farglitazar (GI-262570) is a PPAR-γ agonist and insulin sensitizer that inhibits stellate cell activation by activating receptor γ via oxidative enzymes proliferators and is used in the study of diabetes.
  • Description
    Farglitazar is a PPARγ agonist that has significant therapeutic benefits such as glycemic control in type 2 diabetic patients.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    196808-45-4
  • Formula Weight
    546.61
  • Molecular Formula
    C34H30N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=O)(C1=C(N[C@@H](CC2=CC=C(OCCC=3N=C(OC3C)C4=CC=CC=C4)C=C2)C(O)=O)C=CC=C1)C5=CC=CC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chen L, Yang B, McNulty JA, et al. GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther. 2005;312(2):718-725. ?
molnova catalog
related products
  • Verbenalin

    Verbenalin induces angiogenesis via a programmed PI3K/Akt/eNOS/VEGF signaling axis.

  • ARH-049020

    ARH-049020 (ARH049020) is a PPAR agonist used in the study of type 2 diabetes.

  • Lonazolac

    Lonazolac is a nonsteroidal anti-inflammatory drug.